Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY6 | Q15077 | 6/20 | 0.34 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | P2RY2 | P41231 | 2/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.33 |
| ▸ | GALR3 | O60755 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12537697 | 0.94 | P2RY6 (0.33) | P2RY6P2RY14LMNATHRBSMN1; SMN2 | |
| SCHEMBL6664446 | 0.83 | P2RY2 (0.45) | P2RY6P2RY14LMNATHRBSMN1; SMN2 | |
| SCHEMBL12990877 | 0.82 | P2RY6 (0.32) | P2RY6P2RY14NT5EMAPTP2RY2 | |
| SCHEMBL17706388 | 0.80 | MAPT (0.32) | MAPT | |
| SCHEMBL26359881 | 0.79 | P2RY6 (0.31) | P2RY6P2RY14P2RY2 | |
| SCHEMBL24878606 | 0.79 | TYMP (0.37) | P2RY6P2RY14NT5EP2RY2P2RY4 | |
| SCHEMBL13715722 | 0.79 | TYMP (0.37) | P2RY6P2RY14NT5EP2RY2P2RY4 | |
| SCHEMBL3915198 | 0.79 | TYMP (0.37) | P2RY6P2RY14NT5EP2RY2P2RY4 | |
| SCHEMBL31229956 | 0.79 | TYMP (0.37) | P2RY6P2RY14NT5EP2RY2P2RY4 | |
| SCHEMBL29195406 | 0.79 | TYMP (0.37) | P2RY6P2RY14NT5EP2RY2P2RY4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8158763-B2 | Lipophilic protected, asparagine-linked oligosaccharide derivative containing a fucose in N-acetylglucosamine on nonreducing terminal side | Kajihara, Yasuhiro (JP) | 2012-04-17 | — | — | US | disclosed |
| US-8063202-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2011-11-22 | — | — | US | disclosed |
| US-7943763-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL HOLDINGS CO., LTD. (JP) | 2011-05-17 | — | — | US | disclosed |
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | GLYTECH, INC. (JP) | 2009-09-17 | — | — | US | disclosed |
| US-7304148-B2 | Sugar chain asparagine derivatives, sugar chain asparagine, sugar chain, and processes for producing these | OTSUKA CHEMICAL CO., LTD. (JP) | 2007-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090234095-A1 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | ASNS, ANPEP, B3GNT2 | P2RY6 4445/4885P2RY14 4059/4885LMNA 1552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.